Parexel International has entered a definitive purchase agreement to acquire the business and operations of California Clinical Trials Medical Group, Inc. (CCT) and Behavioral and Medical Research, LLC (BMR) for $65 million. CCT and BMR provide a broad range of specialty Phase I-IV research services through four clinical sites in CA and are headquartered in San Diego. The acquisition is expected to close within the next 30 days. “The acquisition will further strengthen our global Clin...